Kovaltry
Antihemophilic Factor (Recombinant) · KIT · Bayer HealthCare LLC
Kovaltry is a recombinant antihemophilic factor used to treat hemophilia A by replacing clotting factor VIII that the body cannot produce on its own. It comes as a kit for injection and helps prevent or control bleeding episodes in patients with this inherited blood disorder.
Key Facts
- Brand Name
- Kovaltry
- Generic Name
- Antihemophilic Factor (Recombinant)
- NDC Code (Product)
0026-3826- Manufacturer
- Bayer HealthCare LLC
- Dosage Form
- KIT
- Marketing Status
- Application #
- BLA125574
- Marketing Start
- 03/17/2016
Recall History
No Recall HistoryFrequently Asked Questions
What is Kovaltry used for?
Kovaltry is a recombinant antihemophilic factor used to treat hemophilia A by replacing clotting factor VIII that the body cannot produce on its own. It comes as a kit for injection and helps prevent or control bleeding episodes in patients with this inherited blood disorder.
Is Kovaltry a controlled substance?
Kovaltry is not classified as a controlled substance by the DEA.
What is the generic name for Kovaltry?
The generic name for Kovaltry is Antihemophilic Factor (Recombinant). There are 9 other brand versions of Antihemophilic Factor (Recombinant).
What is the NDC code for Kovaltry ?
The NDC (National Drug Code) for Kovaltry is 0026-3826, listed by Bayer HealthCare LLC.